Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons
<p>Abstract</p> <p>Background</p> <p>Triptans, 5-HT<sub>1B/ID </sub>agonists, act on peripheral and/or central terminals of trigeminal ganglion neurons (TGNs) and inhibit the release of neurotransmitters to second-order neurons, which is considered as one of...
Main Authors: | Matsuzawa Yoshiyasu, Morikawa Tomoko, Makita Koshi, Katayama Yoshifumi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2006-03-01
|
Series: | Molecular Pain |
Online Access: | http://www.molecularpain.com/content/2/1/10 |
Similar Items
-
Myocardial infarction after taking zolmitriptan
by: Hélder Ribeiro, et al.
Published: (2012-02-01) -
Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats
by: El-Nabarawy NA, et al.
Published: (2019-11-01) -
Pituitary hormones are specifically expressed in trigeminal sensory neurons and contribute to pain responses in the trigeminal system
by: Anahit H. Hovhannisyan, et al.
Published: (2021-09-01) -
Potential Antimigraine Effects of Warfarin: An Exploration of Biological Mechanism with Survey of Patients
by: Benjamin Nilsson, et al.
Published: (2019-04-01) -
Differential sensitivity of cinnamaldehyde-evoked calcium fluxes to ruthenium red in guinea pig and mouse trigeminal sensory neurons
by: Parmvir K. Bahia, et al.
Published: (2021-04-01)